share_log

Rosenblatt Maintains Buy on Dolby Laboratories, Raises Price Target to $90

Benzinga Real-time News ·  Feb 3, 2023 08:28

Rosenblatt analyst Steve Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and raises the price target from $85 to $90.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment